Filing Flows › Astera Labs (ALAB) › Q3 2026 › vs Q2 2026
Astera Labs (ALAB) Q3 2026 vs Q2 2026 (quarter over quarter)
Astera Labs's revenue rose $192M (+49%) from $392M in Q2 2026 to $585M in Q3 2026. Gross margin 72.3% against 73.3% (-1.0 pts).
Astera Labs, Q3 2026: revenue $585M (+154% year over year), operating margin 30.6%, net earnings $183M, operating cash flow $179M. The chart draws each line against Q2 2026, the increases inside each band.
Margins
| Q3 2026 | Q2 2026 | Change | |
|---|---|---|---|
| Gross margin | 72.3% | 73.3% | -1.0 pts |
| Operating margin | 30.6% | 22.7% | +7.9 pts |
| Net margin | 31.3% | 39.0% | -7.7 pts |
| Free cash flow margin | 22.9% | 17.1% | +5.8 pts |
Every line
| Line | Q3 2026 | Q2 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $585M | $392M | $192M | +49% |
| Gross profit | $423M | $288M | $135M | +47% |
| Cost of revenue | $162M | $105M | $57.3M | +55% |
| Other income, net | $13.0M | $13.6M | −$606K | -4% |
| Operating profit | $179M | $89.2M | $89.8M | +101% |
| Operating expenses | $244M | $198M | $45.4M | +23% |
| Pre-tax earnings | $192M | $103M | $89.2M | +87% |
| Research & development | $171M | $136M | $35.1M | +26% |
| Sales & marketing | $37.4M | $26.4M | $11.1M | +42% |
| General & admin | $35.3M | $36.0M | −$742K | -2% |
| Net earnings | $183M | $153M | $29.9M | +20% |
| Income tax | $9.1M | −$50.3M | $59.3M | — |
| Depreciation & amortization | $5.0M | $3.9M | $1.1M | +28% |
| Share-based compensation | $82.6M | $64.0M | $18.6M | +29% |
| Working capital & other | $91.4M | $133M | −$42.0M | -31% |
| Operating cash flow | $179M | $87.7M | $91.5M | +104% |
| Free cash flow (OCF − capex) | $134M | $67.2M | $66.7M | +99% |
| Capital expenditures | $45.3M | $20.5M | $24.8M | +121% |
Questions
How much did Astera Labs's revenue grow quarter over quarter in Q3 2026?
Astera Labs's revenue rose $192M (+49%) from $392M in Q2 2026 to $585M in Q3 2026. Gross margin 72.3% against 73.3% (-1.0 pts).